Latest Gene Discovery News

Canadian research team makes safe iPS cells by the millionsUniversity of Calgary researchers Derrick Rancourt, PhD, and Roman Krawetz, PhD, have perfected a new bioreactor technology that allows them to make millions of pluripotent stem cells much more quickly than ever before. “The even better news is, we...

Sanofi to Start China Clinical Trial of Cancer Drug In-licensed from SIBSSanofi hopes to begin a Phase I clinical trial in China next year of a novel drug that targets liver cancer. The molecule inhibits the slit-robo signaling path that controls tumor vasculature and tumor growth, a discovery made by researchers at th...

Environmentalism and anti-science, how GMOs prove any ideological extremity leads to anti-scienceDenialism blog has a say about the schermozzle looming at the Rothamsted UK agricultural research unit about the organic farming protest mob Take the Flour Back's threat to sabotage legitimate science experiments:Today I read about two individuals who decided on political defections over perceived anti-science amongst their former political allies- one due to climate change, the other for anti-GMO...

Senator seeks to extend therapeutic tax creditSen. Robert Menendez (D-N.J.) introduced a bill that would extend the therapeutic discovery project program (TDPP) by an additional $1 billion in 2012. The program, which originally provided $1 billion through the end of 2010, was designed to provide...

Oldest Jewish archaeological evidence on the Iberian PeninsulaOn a marble plate, measuring 40 by 60 centimetres, the name "Yehiel" can be read, followed by further letters which have not yet been deciphered. The Jena Archaeologists believe that the new discovery might be a tomb slab. Antlers, which were found v...

MDxHealth: Annual and Extraordinary General Shareholders’ MeetingRegulatory News: MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, held its Annual and Extraordinary General Meeting of shareholders in Zaventem today. The shareholders approved all agenda items of the Annual General Meeting, including th...

A.M. Vitals: Shrinking School Budgets Hit Nurse’s OfficeAlso: Researchers say they have identified a gene that's important for producing sperm, a potential target for contraceptive pills; and a study suggests metabolic factors may be more important than obesity in predicting heart-disease risk.

Summit Corporation shares up as starts Phase 1 trials of SMT C1100Shares in Summit Corporation (LON:SUMM) advanced 5 per cent today as it revealed it had started a phase 1 trial on its potentially breakthrough treatment for Duchenne Muscular Dystrophy. The drug discovery company said it had dosed the first cohort...

Overactive BAALC gene found in people with acute leukemiaA small inherited change in DNA is largely responsible for overactivating a gene linked to poor treatment response in people with acute leukemia.

In vivo selection of autologous MGMT gene-modified cells following reduced-intensity conditioning with BCNU and temozolomide in the dog model

Major Scientific Conference Convened to Review The Safety Of GMO CropsA major international conference scientific meeting titled “Risk Assessment in Agricultural Biotechnology” was held at the University of California, Davis. It was sponsored by the College of Agriculture, The National Association of Stat...

Cellectricon introduces Cellaxess discovery platformCellectricon has launched a new Cellaxess elektra discovery platform for automated electric field manipulation of adherent cells.

News and press releases: European Medicines Agency recommends first-in-class medicine for treatment of cystic fibrosisThe European Medicines Agency has recommended Kalydeco (ivacaftor), an orphan-designated medicine, for the treatment of cystic fibrosis in patients age 6 years and older who have a G551D mutation in the cystic fibrosis transmembrane regulator (CFTR)...

Vertex Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic FibrosisVertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion by consensus recommending the approval of KALYDECO™ (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have at least one copy of the G551D mutation in the cystic fibros...

Vertex Pharma receives European recommendation for approval of cystic fibrosis drugVertex Pharmaceuticals (NASDAQ:VRTX) announced Friday that it has received the positive opinion of the European Committee for Medicinal Products for Human Use (CHMP), which recommended the approval of Kalydeco (ivacaftor) for cystic fibrosis. The com...

Cancer may require simpler genetic mutations than previously thoughtChromosomal deletions in DNA often involve just one of two gene copies inherited from either parent. But scientists haven't known how a deletion in one gene from one parent, called a "hemizygous" deletion, can contribute to cancer.

Inherited DNA change explains overactive leukemia geneA small inherited change in DNA is largely responsible for overactivating a gene linked to poor treatment response in people with acute leukemia.

New Custom-Built Mesoporous Silica Nanoparticles Help Advance Gene EditingBy Nick Gilbert Scientists at Iowa State University have developed new custom-built mesoporous silica nanoparticles that enable co-delivery of functional DNA and proteins into plant cells. These...

US Senator calls for prizes not patents for drug discoveryA radical idea has been proposed by a US Senator calling for patents on drugs to be scrapped and instead an annual prize fund set up, which would reward the discovery of new treatments. These treatments would then, due to competition, become availabl...

Energy levels link sleep control mechanismsSleep, or lack of it, can determine level of cognitive performance which is linked with accidents as well as increased risk of serious health problems. Links between cell energy levels, gene transcription and sleep rhythms may uncover answers to slee...

Regional Differences in Subcutaneous Adipose Tissue Gene Expression

European CHMP issues positive opinion to Vertex's KALYDECO for treatment of CFVertex Pharmaceuticals Incorporated announced today that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion by consensus recommending the approval of KALYDECO (ivacaftor) for people with cystic fibrosis (...

Oncobiologics Fills Key Leadership Positions and Names Scientific Advisory BoardCRANBURY, N.J., May 25, 2012 /PRNewswire/ -- Oncobiologics, Inc. announced today that it has filled two important leadership positions with established biopharmaceutical industry experts. Stephen J. McAndrew, Ph.D. is now Vice President, Business Development and Vincent J. Benn, Ph.D. has joined the company as Vice President, Clinical & Regulatory Affairs. The company also announced its n...

Gene therapy can effectively treat ADA-deficient severe combined immunodeficiencySevere combined immunodeficiency is defect in the immune system that results in a loss of the adaptive immune cells known as B cells and T cells. Mutations in several different genes can lead to the development of severe combined immunodeficiency, in...

University of Kentucky researcher receives $1.8M NIH grant to study CFDavid Feola, a University of Kentucky College of Pharmacy faculty member in the Department of Pharmacy Practice and Science, received a five-year, $1.8 million grant from the National Institutes of Health (NIH) to continue his research investigating...

0 1 2 3 4 ›»

buy Gene Discovery market research data and corporate reports now Advertisement